Edward Li
Impact in
- Geriatrics and Gerontology top 10%
-
- Cancer-related Molecular Pathways
- Neutropenia and Cancer Infections
Papers in
- Oncology 12
- Neutropenia and Cancer Infections 9
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Pharmaceutical Economics and Policy 7
- Co-authors
- James M. Hoffman (4 shared papers)Hui-Zi Chen (1 shared paper)Whitney M. Cleghorn (1 shared paper)Cong Ran (1 shared paper)Michael Weinstein (1 shared paper)Jing Li (1 shared paper)Shusil K. Pandit (1 shared paper)Alain de Bruin (1 shared paper)
- Journals
- Journal of Managed Care & Specialty Pharmacy (6 papers)American Journal of Health-System Pharmacy (5 papers)Journal of the American Academy of Dermatology (2 papers)JCO Oncology Practice (2 papers)Journal of the National Comprehensive Cancer Network (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Edward Li
37 papers receiving 657 citations
Peers
Comparison fields: 5 of 115
- Geriatrics and Gerontology 26
- Oncology 177
- Family Practice 13
- Clinical Biochemistry 35
- Immunology 108
Countries citing papers authored by Edward Li
This map shows the geographic impact of Edward Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Li more than expected).
Fields of papers citing papers by Edward Li
This network shows the impact of papers produced by Edward Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Li. The network helps show where Edward Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 170 | |
| 2 | 2017 | 121 | |
| 3 | 2012 | 60 | |
| 4 | 2015 | 34 | |
| 5 | 2014 | 32 | |
| 6 | 2018 | 31 | |
| 7 | 2020 | 27 | |
| 8 | 2012 | 23 | |
| 9 | 2016 | 16 | |
| 10 | 2013 | 16 | |
| 11 | 2017 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2015 | 13 | |
| 14 | 2015 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2021 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2015 | 6 | |
| 20 | 2017 | 6 |
About Edward Li
Edward Li is a scholar working on Oncology, Economics and Econometrics, Immunology, Molecular Biology and Surgery, having authored 41 papers that have together received 672 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (9 papers), Biosimilars and Bioanalytical Methods (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (7 papers), Pharmaceutical studies and practices (3 papers), Chemotherapy-related skin toxicity (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Geriatrics and Gerontology (26 citations), Oncology (177 citations), Family Practice (13 citations), Clinical Biochemistry (35 citations) and Immunology (108 citations). Edward Li has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include James M. Hoffman, Hui-Zi Chen, Whitney M. Cleghorn, Cong Ran, Michael Weinstein, Jing Li, Shusil K. Pandit, Alain de Bruin, Gustavo Leone and Karl Kornacker. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, American Journal of Health-System Pharmacy, Journal of the American Academy of Dermatology, JCO Oncology Practice and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.